Although uNSCLC has different pathological features from cNCSLC, tumor PD-L1 expression (TPS ≥ 1%) was observed in ~ 60% of the patients with uNSCLC and was also predictive for efficacy of ICIs. Here, CD274 is linked to neoplasm.